Multilevel Models for Meta-Analysis

[1]  Matthew P. Longnecker,et al.  Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review , 2005, Cancer Causes & Control.

[2]  K K Yau,et al.  Long-term survivor mixture model with random effects: application to a multi-centre clinical trial of carcinoma. , 2001, Statistics in medicine.

[3]  Dk Pauler,et al.  Modeling and Implementation Issues in Bayesian Meta-Analysis , 2000 .

[4]  Nick Freemantle,et al.  β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .

[5]  R. Kass,et al.  Reference Bayesian Methods for Generalized Linear Mixed Models , 2000 .

[6]  J. Carlin.  Meta-analysis for 2 x 2 tables: a Bayesian approach. , 1992, Statistics in medicine.

[7]  F Mosteller,et al.  Meta-analysis of multiple outcomes by regression with random effects. , 1998, Statistics in medicine.

[8]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[9]  Keith R. Abrams,et al.  Meta-analysis of Heterogeneously Reported Study Results: A Bayesian Approach , 2000 .

[10]  Douglas G Altman,et al.  The relation between treatment benefit and underlying risk in meta-analysis , 1996, BMJ.

[11]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[12]  D J Spiegelhalter,et al.  Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.

[13]  S. Sharp,et al.  Explaining heterogeneity in meta-analysis: a comparison of methods. , 1999 .

[14]  A Briggs,et al.  The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.

[15]  S G Thompson,et al.  Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.

[16]  C S Berkey,et al.  A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.

[17]  D. Altman,et al.  Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice , 2002, Journal of health services research & policy.

[18]  S. Pocock,et al.  Can meta-analyses be trusted? , 1991, The Lancet.

[19]  H Goldstein,et al.  A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.

[20]  A. Logan,et al.  Statistical Issues in a Metaregression Analysis of Randomized Trials: Impact on the Dietary Sodium Intake and Blood Pressure Relationship , 1999, Biometrics.

[21]  H. Goldstein.  Multilevel Statistical Models , 2006 .

[22]  P. Royston,et al.  Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .

[23]  Donald A. Berry,et al.  Meta-Analysis in Medicine and Health Policy , 2000 .

[24]  R Peto,et al.  Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.

[25]  D J Spiegelhalter,et al.  Bayesian methods for cluster randomized trials with continuous responses. , 2001, Statistics in medicine.

[26]  A Whitehead,et al.  Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.

[27]  George Davey Smith,et al.  Meta-analysis: Beyond the grand mean? , 1997, BMJ.

[28]  S G Thompson,et al.  Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. , 2000, Statistics in medicine.

[29]  Eric S. Johnson,et al.  A metaregression analysis of the dose-response effect of aspirin on stroke. , 1999, Archives of internal medicine.

[30]  David R. Jones,et al.  Meta-analysis: weighing the evidence. , 1995, Statistics in medicine.

[31]  S. Assmann,et al.  Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.

[32]  H. Goldstein,et al.  Meta‐analysis using multilevel models with an application to the study of class size effects , 2000 .

[33]  D O Stram,et al.  Meta-analysis of published data using a linear mixed-effects model. , 1996, Biometrics.

[34]  D. P. Gaver,et al.  Combining Information: Statistical Issues and Opportunities for Research , 1993 .

[35]  J C Wakefield,et al.  Hierarchical models for multicentre binary response studies. , 1990, Statistics in medicine.

[36]  Walter R. Gilks,et al.  A Language and Program for Complex Bayesian Modelling , 1994 .

[37]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[38]  A Whitehead,et al.  Meta‐analysis of ordinal outcomes using individual patient data , 2001, Statistics in medicine.

[39]  David R. Jones,et al.  Systematic reviews of trials and other studies. , 1998, Health technology assessment.

[40]  M. McIntosh,et al.  The population risk as an explanatory variable in research synthesis of clinical trials. , 1996, Statistics in medicine.

[41]  D. Spiegelhalter,et al.  Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales , 2002, Statistics in medicine.

[42]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[43]  P C Lambert,et al.  A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.

[44]  J. Hutton,et al.  Number needed to treat: properties and problems , 2000 .